<DOC>
	<DOCNO>NCT00168207</DOCNO>
	<brief_summary>The aim investigate hypothesis IL7-receptor polymorphism contribute differential immune recovery CD4 + T cell follow HAART</brief_summary>
	<brief_title>IL-7 Receptor Polymorphisms Immune Recovery With HAART</brief_title>
	<detailed_description>AIM : To examine association four haplotypes IL-7Rα gene cohort HIV infect patient commenced HAART vary CD4+ T lymphocyte response . METHODS : IL-7Rα gene SNPs haplotype measure construct DNA pool , PCR amplification DNA sequencing . IL-7Rα expression examine use constitutive expression IL-7Rα , IL-7Rα gene expression , inducible expression IL7Rα .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Men woman least 18 year age First antiretroviral regimen compose HAART define least three antiretrovirals Controlled viremia period least 12 month follow commencement HAART . Controlled viremia define HIV viral load ≤ 500 copies/mL bDNA test ( version 2 3 ) &lt; 400 copies/ml measure RTPCR assay 6 month treatment . CD4 cell count &lt; 500 commencement HAART Measurement CD4+ cell count least 3 time point , 12 month post commencement HAART . Exclude patient treat HIV seroconversion illness Exclude patient immunomodulatory therapy IL2 , hydroxyurea prednisolone receive HIV therapeutic vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Treatment Experienced</keyword>
	<keyword>HIV</keyword>
</DOC>